Clinical Trials Directory

Trials / Completed

CompletedNCT02350738

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for People With Mild Cognitive Impairment and Early Stage Dementia: a Randomized, Controlled, Double-blind, Cross-over Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Ki Woong Kim · Academic / Other
Sex
All
Age
55 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effects of Multimodal Cognitive Enhancement Therapy (MCET) for people with mild cognitive impairment and early stage dementia by a randomized, controlled (mock-therapy), double-blind, cross-over trial

Detailed description

Multimodal Cognitive Enhancement Therapy (MCET) was developed for cognitive rehabilitation of mild cognitive impairment or ealy dementia. MCET consists of cognitive training, cognitive stimulation, reality orientation, physical therapy, reminiscence therapy and music therapy that obtained 'A' grade of recommendation by SIGN(Scottish Intercollegiate Guidelines Network) for their efficacy (one of the followings: global cognition/specific cognitive domain/mood/activities of daily living/behavioral and psychological symptoms/quality of life) based on the systematic review and meta-analysis performed by our research team. This study investigated the efficacy of MCET compared with mock-therapy that consisted of random activities that were not based on clinical evidences (e.g., watching TV, conversation etc.).

Conditions

Interventions

TypeNameDescription
OTHERPeriod I MCET (8 wks)MCET\_Mock group: Multimodal Cognitive Enhancement Therapy (MCET) (3 sessions/wk) Mock\_MCET group: mock-therapy (3 sessions/wk)
OTHERWashout (4 wks)4 weeks wash-out period in both arms and cross-over
OTHERPeriod II MCET (8 wks)MCET\_Mock group: mock therapy (MCET) (3 sessions/wk) Mock\_MCET group: Multimodal Cognitive Enhancement Therapy (MCET) (3 sessions/wk)

Timeline

Start date
2014-02-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-01-30
Last updated
2015-07-28

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02350738. Inclusion in this directory is not an endorsement.